Board Meeting7 Sept 2026, 07:31 pm
Tavexia Lifecare Board Approves Auditor Change, Explores Meyonex Acquisition
AI Summary
Tavexia Lifecare Ltd's Board of Directors met on September 7, 2026, approving the resignation of statutory auditors M/s SSRV & Associates and the appointment of M/s DEVAM & Associates LLP as their replacement, subject to member approval. The board also approved the re-appointment of Mrs. Khushboo Vasudev as an Independent Director for a second five-year term. Additionally, the board discussed and authorized preliminary evaluation and due diligence for a potential acquisition of up to 60% equity share capital in Meyonex Pharmaceuticals Limited.
Key Highlights
- Resignation of statutory auditors SSRV & Associates accepted.
- DEVAM & Associates LLP appointed as new statutory auditors.
- Mrs. Khushboo Vasudev re-appointed as Independent Director.
- Exploration of acquiring up to 60% of Meyonex Pharmaceuticals approved.
- Directors authorized to conduct due diligence and negotiations for acquisition.
Price Impact
More from SATTVASUKU